# EDGAR Filing Document

**Accession Number:** 0001900304
**File Stem:** 0001654954-26-004322
**Filing Date:** 2026-5
**Character Count:** 7061
**Document Hash:** a25e6b4697e07818b65e8946109649fb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-26-004322.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0001654954-26-004322

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260505

**FILED AS OF DATE**: 20260505

**DATE AS OF CHANGE**: 20260505

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Haleon plc
- **CENTRAL INDEX KEY:** 0001900304
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41411
- **FILM NUMBER:** 26940322

**BUSINESS ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY
- **BUSINESS PHONE:** 44 1932 822000

**MAIL ADDRESS:**
- **STREET 1:** BUILDING 5, FIRST FLOOR
- **STREET 2:** THE HEIGHTS
- **CITY:** WEYBRIDGE
- **STATE:** X0
- **ZIP:** KT13 0NY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DRVW 2022 Ltd
- **DATE OF NAME CHANGE:** 20211217

 **UNITED STATES**

 **SECURITIES AND EXCHANGE COMMISSION**

 **Washington, D.C. 20549**

 **FORM 6-K**

 **REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934**

 **For the month of May 2026**

 **Commission File Number: 001-41411**

 **Haleon plc**

(Translation of registrant's name into English)

 **Building 5, First Floor, The Heights,**

 **Weybridge, Surrey, KT13 0NY**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

 **EXHIBIT INDEX**

<u> <u>Exhibit Number</u> </u> <u>Description</u> <br> <u> 99.1 </u> <u> 05 May 2026 - "Transactions in Own Shares" </u>

99.1 ![](a8863c000.jpg)

 **Haleon plc: Aggregated information - transactions in own shares**

 **5 May 2026:** Haleon plc (the "Company" or "Haleon") today announces the purchase of 12,171,987 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under its share buyback programme announced on 12 March 2026.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **London Stock Exchange** | **CBOE (UK)/BXE** | **CBOE (UK)/CXE** | **Aquis** |
| Date of purchase: | 27 April 2026 | 27 April 2026 | 27 April 2026 | 27 April 2026 |
| Number of Shares purchased: | 1308429 | 656619 | 797997 | - |
| Highest price paid per Share (p): | 353.3000 | 353.3000 | 353.3000 | - |
| Lowest price paid per Share (p): | 349.4000 | 349.4000 | 349.4000 | - |
| Volume weighted average price paid per Share (p): | 350.8780 | 350.7867 | 350.8309 | - |
| Date of purchase: | 28 April 2026 | 28 April 2026 | 28 April 2026 | 28 April 2026 |
| Number of Shares purchased: | 556329 | 371197 | 472474 | - |
| Highest price paid per Share (p): | 351.8000 | 351.8000 | 351.8000 | - |
| Lowest price paid per Share (p): | 348.5000 | 348.4000 | 348.5000 | - |
| Volume weighted average price paid per Share (p): | 349.9766 | 349.9554 | 349.9275 | - |
| Date of purchase: | 29 April 2026 | 29 April 2026 | 29 April 2026 | 29 April 2026 |
| Number of Shares purchased: | 2359494 | 1639812 | 898835 | 347887 |
| Highest price paid per Share (p): | 359.6000 | 359.6000 | 360.0000 | 345.3000 |
| Lowest price paid per Share (p): | 333.8000 | 333.8000 | 334.5000 | 336.5000 |
| Volume weighted average price paid per Share (p): | 338.4335 | 338.3904 | 339.5767 | 340.2554 |
| Date of purchase: | 30 April 2026 | 30 April 2026 | 30 April 2026 | 30 April 2026 |
| Number of Shares purchased: | 524892 | 381406 | 391616 | - |
| Highest price paid per Share (p): | 342.9000 | 342.9000 | 342.8000 | - |
| Lowest price paid per Share (p): | 338.7000 | 338.7000 | 338.7000 | - |
| Volume weighted average price paid per Share (p): | 340.6250 | 340.6757 | 340.6498 | - |
| Date of purchase: | 1 May 2026 | 1 May 2026 | 1 May 2026 | 1 May 2026 |
| Number of Shares purchased: | 639274 | 249799 | 575927 | - |
| Highest price paid per Share (p): | 343.8000 | 343.1000 | 343.8000 | - |
| Lowest price paid per Share (p): | 336.0000 | 336.0000 | 336.0000 | - |
| Volume weighted average price paid per Share (p): | 339.4396 | 339.5013 | 339.4039 | - |

---

Following the settlement of the above, the Company's registered share capital is 8,890,467,595 ordinary shares of £0.01 each, of which 12,240,797 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,878,226,798 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:

<u>http://www.rns-pdf.londonstockexchange.com/rns/8862C_1-2026-5-1.pdf</u>

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This announcement and individual trade breakdown will also be available on the Company's website at: <u>www.haleon.com/investors</u>.

---

| | | | |
|:---|:---|:---|:---|
| **Enquiries** | **Enquiries** |  |  |
| **Investors** | **Investors** | **Media** | **Media** |
| Jo Russell  | +44 7787 392441 | Zoë Bird | +44 7736 746167 |
| Rakesh Patel  | +44 7552 484646 | Victoria Durman | +44 7894 505730 |
| Email: <u>investor-relations@haleon.com</u> | Email: <u>investor-relations@haleon.com</u> | Email: <u>corporate.media@haleon.com</u> | Email: <u>corporate.media@haleon.com</u> |

---

 **About Haleon**

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as *Advil*, *Centrum*, *Otrivin*, *Panadol*, *parodontax*, *Polident*, *Sensodyne*, *Theraflu* and *Voltaren* - are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit <u>www.haleon.com</u>.

 **SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | **HALEON PLC**<br> *(Registrant)* | **HALEON PLC**<br> *(Registrant)* |
| Date: May 05, 2026 | By: | /s/ Amanda Mellor | /s/ Amanda Mellor |
|  |  | Name: | Amanda Mellor |
|  |  | Title: | Company Secretary |

---